Shanghai Sanyou Medical Co., Ltd (SHA:688085)
China · Delayed Price · Currency is CNY 13.07
+0.17 (1.32%)
Nov 13, 2026, 3:00 PM CST
Shanghai Sanyou Medical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 299.76 | 335.65 | 403.09 | 654.35 | 340.43 | 382.31 |
Short-Term Investments | - | 205.04 | 234.84 | - | - | - |
Trading Asset Securities | 216.28 | 240.56 | 50.23 | 19.63 | 193.1 | 376.63 |
Cash & Short-Term Investments | 516.04 | 781.25 | 688.16 | 673.98 | 533.53 | 758.94 |
Cash Growth | -7.27% | 13.53% | 2.10% | 26.32% | -29.70% | -33.61% |
Accounts Receivable | 120.24 | 96.73 | 73.14 | 61.53 | 275.37 | 252.88 |
Other Receivables | 1.72 | 1.99 | 3.98 | 0.94 | 2.75 | 2.4 |
Receivables | 121.95 | 98.72 | 77.12 | 62.46 | 278.12 | 255.29 |
Inventory | 306.21 | 282.95 | 246.11 | 176.66 | 155.08 | 121.48 |
Other Current Assets | 233.55 | 15.38 | 22.25 | 33.19 | 27.68 | 14.91 |
Total Current Assets | 1,178 | 1,178 | 1,034 | 946.3 | 994.41 | 1,151 |
Property, Plant & Equipment | 332.9 | 337.73 | 346.58 | 344.09 | 345.42 | 256.31 |
Long-Term Investments | 400.5 | 385.25 | 426.39 | 490.05 | 425.25 | 182.33 |
Goodwill | 345.87 | 345.87 | 345.87 | 315.3 | 315.23 | 315.23 |
Other Intangible Assets | 88.94 | 96.87 | 88.71 | 85.59 | 40.98 | 32.81 |
Long-Term Deferred Tax Assets | 12.07 | 6.9 | 3.8 | 22.69 | 33.65 | 30.27 |
Long-Term Deferred Charges | 25.42 | 25.19 | 32.49 | 45.58 | 26.17 | 22.74 |
Other Long-Term Assets | 9.96 | 0.79 | 29.19 | 11.88 | 10.26 | 6.87 |
Total Assets | 2,393 | 2,377 | 2,307 | 2,261 | 2,191 | 1,997 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 84.22 | 55.63 | 58.44 | 26.69 | 28.06 | 20.25 |
Accrued Expenses | 25.98 | 62.72 | 56.08 | 79.24 | 126.02 | 122.59 |
Short-Term Debt | 19.89 | 19.96 | 15.25 | - | - | - |
Current Portion of Long-Term Debt | 8.79 | 6.65 | 8.5 | - | - | - |
Current Portion of Leases | - | 5.93 | 6.76 | 4.15 | 3.08 | 2.59 |
Current Income Taxes Payable | 17.28 | 5.72 | 1.46 | 1.09 | 12.81 | 13.67 |
Current Unearned Revenue | 1.54 | 0.63 | 6.23 | 4.74 | 9.73 | 10.7 |
Other Current Liabilities | 70.33 | 71.12 | 72.11 | 78.54 | 65.35 | 65.13 |
Total Current Liabilities | 228.05 | 228.36 | 224.84 | 194.45 | 245.05 | 234.92 |
Long-Term Debt | 40.06 | 2.03 | 8.38 | - | - | - |
Long-Term Leases | 3.67 | 6.87 | 8 | 0.83 | 2.3 | 2.49 |
Long-Term Unearned Revenue | 7.03 | 6.21 | 7.12 | 6.69 | 7.85 | 6.83 |
Pension & Post-Retirement Benefits | 1.91 | 1.85 | 1.64 | - | - | - |
Long-Term Deferred Tax Liabilities | 4.96 | 5.86 | 6.9 | 16.11 | 10.6 | 4.1 |
Other Long-Term Liabilities | 0.34 | 0.97 | 1.04 | 0.72 | 12.56 | 12.56 |
Total Liabilities | 286.02 | 252.14 | 257.91 | 218.8 | 278.35 | 260.9 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 366.81 | 333.46 | 248.45 | 248.45 | 225.87 | 205.33 |
Additional Paid-In Capital | 1,056 | 1,066 | 1,016 | 1,012 | 1,035 | 1,055 |
Retained Earnings | 750.62 | 709.6 | 647.66 | 655.57 | 579.19 | 425.74 |
Comprehensive Income & Other | -2.31 | -4.07 | -0.52 | 0.1 | 0.04 | -0 |
Total Common Equity | 2,097 | 2,105 | 1,912 | 1,916 | 1,840 | 1,686 |
Minority Interest | 9.96 | 20 | 136.95 | 126.51 | 73.27 | 50.42 |
Shareholders' Equity | 2,107 | 2,125 | 2,049 | 2,043 | 1,913 | 1,736 |
Total Liabilities & Equity | 2,393 | 2,377 | 2,307 | 2,261 | 2,191 | 1,997 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 72.42 | 41.43 | 46.9 | 4.99 | 5.39 | 5.07 |
Net Cash (Debt) | 443.63 | 739.82 | 641.26 | 669 | 528.15 | 753.86 |
Net Cash Growth | -13.50% | 15.37% | -4.15% | 26.67% | -29.94% | -34.05% |
Net Cash Per Share | 1.21 | 2.02 | 2.04 | 2.02 | 1.61 | 2.31 |
Filing Date Shares Outstanding | 361.33 | 366.81 | 366.81 | 327.96 | 327.96 | 327.96 |
Total Common Shares Outstanding | 361.33 | 366.81 | 327.96 | 327.96 | 327.96 | 327.96 |
Working Capital | 949.71 | 949.94 | 808.8 | 751.85 | 749.37 | 915.68 |
Book Value Per Share | 5.80 | 5.74 | 5.83 | 5.84 | 5.61 | 5.14 |
Tangible Book Value | 1,663 | 1,662 | 1,477 | 1,515 | 1,484 | 1,338 |
Tangible Book Value Per Share | 4.60 | 4.53 | 4.50 | 4.62 | 4.52 | 4.08 |
Buildings | - | 256.83 | 257.34 | 257.79 | 246.13 | 105.74 |
Machinery | - | 202.9 | 184.64 | 142.49 | 136.66 | 102.43 |
Construction In Progress | - | 2.94 | 5.46 | 6.53 | 4.62 | 100.06 |